GKOS
Glaukos Corporation
NYSE · USHealthcareMedical - Devices
$155.46-0.87%
Price as of Jul 20, 2026
GKOS capital
Glaukos Corporation capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.15x
- Net debt / equity
- -0.00x
- Debt / assets
- 0.12x
- Debt / EBITDA
- -0.72x
- Net debt / EBITDA
- 0.01x
Liquidity & coverage
- Current ratio
- 5.43x
- Quick ratio
- 4.73x
- Cash ratio
- 3.09x
- Interest coverage
- -18.69x
- EBITDA / interest
- -31.33x
- Working capital
- $396.3M
Cash & dividend
- FCF / debt
- -0.18x
- Cash flow / debt
- -0.09x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.